News and History
-
WHO Reports Measles deaths down 88% since 2000, but cases surge
Read More: WHO Reports Measles deaths down 88% since 2000, but cases surgeOn Nov. 28, 2025, the the World Health Organization (WHO) reported that global immunization efforts have led to…
-
China bans pork imports from Barcelona after Spain’s swine fever outbreak
Read More: China bans pork imports from Barcelona after Spain’s swine fever outbreakOn Nov. 28, 2025, China has banned pork imports from Barcelona province after Spain detected its first case…
-
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
Read More: Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancerOn Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
-
Doctors still outperform AI in clinical reasoning, study shows
Read More: Doctors still outperform AI in clinical reasoning, study shows -
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
Read More: U.S. Centers for Disease Control and Prevention to End Monkey Research ProgramOn Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
-
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
Read More: U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder CancerOn Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
-
WHO Reports Diphtheria outbreak in African Region
Read More: WHO Reports Diphtheria outbreak in African RegionOn Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
-
The West Coast Health Alliance Stands with Scientific Evidence: Vaccines Are Not Linked to Autism
Read More: The West Coast Health Alliance Stands with Scientific Evidence: Vaccines Are Not Linked to AutismOn Nov. 21, 2025, state health officials from California, Oregon, Hawaii and Washington issued a statement in response…
-
new antibody test only takes 10 minutes, no blood draw necessary
Read More: new antibody test only takes 10 minutes, no blood draw necessaryOn Nov. 20, 2025, an interdisciplinary research team at the University of Pittsburgh has developed wearable biosensors that…
-
FDA approves first cancer drug based on Broad Institute science
Read More: FDA approves first cancer drug based on Broad Institute scienceOn Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
-
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
Read More: Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority HealthOn Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
-
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
Read More: CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion totalOn Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
-
Neurolgic Form of Equine Herpes Virus Confirmed Following Texas Event
Read More: Neurolgic Form of Equine Herpes Virus Confirmed Following Texas EventOn Nov. 19, 2025, the Texas Animal Health Commission (TAHC) received confirmation of equine herpes myeloencephalopathy (EHM), the…
-
Novartis announces plans to build flagship manufacturing hub in North Carolina
Read More: Novartis announces plans to build flagship manufacturing hub in North CarolinaOn Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
-
CSL injects $2.3b into US for valuable blood plasma
Read More: CSL injects $2.3b into US for valuable blood plasmaOn Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
-
Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
Read More: Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
-
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
Read More: Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplantOn Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
-
Utah, South Carolina confirm more measles as CDC call suggests U.S. elimination status in jeopardy
Read More: Utah, South Carolina confirm more measles as CDC call suggests U.S. elimination status in jeopardy -
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
Read More: Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancerOn Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
-
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Read More: Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilarOn Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
